INS and polycystic ovary syndrome: Metabolically, these individuals exhibit higher fasting and postprandial insulin levels, elevated indices of insulin resistance, and greater disturbances in glucose and lipid metabolism—factors that increase their risk of developing type 2 diabetes (3–5 times higher than non-obese PCOS patients) and cardiovascular diseases [78].